Research / QXL / Fundamental state Inspectable configuration
State dimensions Filing 0001493152-26-037811 General Corporate
Debt relative to revenue 100th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.debt_to_revenue
422.53% · OPTIONAL · VALID
Capex intensity 100th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.capex_revenue_ratio
63.48% · OPTIONAL · VALID
Revenue growth 10th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-87.15% · CORE · VALID
Operating margin 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-476.11% · CORE · VALID
R&D intensity 65th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
63.14% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Jun 30, 2021 0/6 normalized Level 3 Sep 30, 2021 4/6 normalized Level 3 Dec 31, 2021 4/5 normalized Level 3 Mar 31, 2022 4/6 normalized Level 3 Jun 30, 2022 4/6 normalized Level 3 Sep 30, 2022 4/7 normalized Level 3 Sep 30, 2022 4/7 normalized Amended as filed Dec 31, 2022 4/7 normalized Level 3 Mar 31, 2023 4/6 normalized Level 3 Jun 30, 2023 4/7 normalized Level 3 Sep 30, 2023 4/7 normalized Level 3 Dec 31, 2023 4/7 normalized Level 3 Mar 31, 2024 4/6 normalized Level 3 Jun 30, 2024 4/6 normalized Level 3 Sep 30, 2024 5/6 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 5/5 normalized Level 3 Jun 30, 2025 5/5 normalized Level 3 Sep 30, 2025 6/6 normalized Level 3 Jun 30, 2026 5/5 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 106.18%
Current 422.53%
Delta 316.34% Growth Decreased
Previous -56.74%
Current -87.15%
Delta -30.41% Profitability Decreased
Previous -133.71%
Current -476.11%
Delta -342.40% R And D Intensity Increased
Previous 4.23%
Current 63.14%
Delta 58.91% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Jun 30, 2025
Similarity 84%
Compared 3 dimensions
Coverage 60% Growth 21.6 · Profitability 10.0 · R And D Intensity 15.0 Jun 30, 2024
Similarity 79%
Compared 3 dimensions
Coverage 60% Growth 16.7 · Profitability 22.1 · R And D Intensity 22.9 Sep 30, 2023
Similarity 60%
Compared 3 dimensions
Coverage 60% Growth 56.7 · Profitability 30.0 · R And D Intensity 27.5 Dec 31, 2024
Similarity 45%
Compared 5 dimensions
Coverage 100% Growth 19.4 · Profitability 20.0 · Capex Intensity 100.0 · R And D Intensity 20.0 · Balance Sheet Leverage 62.5 Mar 31, 2023
Similarity 38%
Compared 3 dimensions
Coverage 60% Growth 90.0 · Profitability 37.1 · R And D Intensity 43.6 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.